Profiling of miRNA expression in mice kidney with diabetic nephropathy

[1]  Baohong Zhang,et al.  A critical and speculative review on microRNA technology in crop improvement: Current challenges and future directions. , 2018, Plant science : an international journal of experimental plant biology.

[2]  M. Pezzolesi,et al.  Advances in understanding the genetic basis of diabetic kidney disease , 2018, Acta Diabetologica.

[3]  Z. Asemi,et al.  The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression , 2018, Journal of cellular physiology.

[4]  K. Wu,et al.  Update of pathophysiology and management of diabetic kidney disease. , 2018, Journal of the Formosan Medical Association = Taiwan yi zhi.

[5]  S. Najam,et al.  MicroRNAs in the hypothalamic control of energy homeostasis , 2018, Cell and Tissue Research.

[6]  S. Chakrabarti,et al.  Endothelin-1 regulation is entangled in a complex web of epigenetic mechanisms in diabetes. , 2018, Physiological research.

[7]  C. Alpers,et al.  Pathology identifies glomerular treatment targets in diabetic nephropathy , 2018, Kidney research and clinical practice.

[8]  J. Zhen,et al.  Podocyte-specific Rac1 deficiency ameliorates podocyte damage and proteinuria in STZ-induced diabetic nephropathy in mice , 2018, Cell Death & Disease.

[9]  Jingping Liu,et al.  Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment , 2018, International journal of molecular medicine.

[10]  Jongsung Lee,et al.  Profiling of gene expression using microarray in acrolein-treated human pulmonary fibroblasts , 2017, Molecular & Cellular Toxicology.

[11]  H. Jang,et al.  Anti-diabetic effects of natural products an overview of therapeutic strategies , 2017, Molecular & Cellular Toxicology.

[12]  I. Hwang,et al.  Dendropanax morbifera Léveille extract ameliorates memory impairments and inflammatory responses in the hippocampus of streptozotocin-induced type 1 diabetic rats , 2016, Molecular & Cellular Toxicology.

[13]  Mi-Kyung Song,et al.  Expression of exosomal and cellular microRNAs: as biomarkers for toluene, ethylbenzene, xylene (TEX) exposure , 2016, Molecular & Cellular Toxicology.

[14]  A. Giordano,et al.  MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy. , 2016, Anticancer research.

[15]  D. Lacombe,et al.  High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[16]  A. Miranda-Díaz,et al.  Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease , 2016, Journal of diabetes research.

[17]  Zemenu Tamir,et al.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy , 2016, International journal of nephrology.

[18]  I. Yam,et al.  Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress. , 2016, Kidney international.

[19]  W. Bauman,et al.  ANKRD1 modulates inflammatory responses in C2C12 myoblasts through feedback inhibition of NF-κB signaling activity. , 2015, Biochemical and biophysical research communications.

[20]  J. Navarro-González,et al.  Inflammatory Cytokines in Diabetic Nephropathy , 2015, Journal of diabetes research.

[21]  H. Parving,et al.  Improved prognosis of diabetic nephropathy in type 1 diabetes. , 2015, Kidney international.

[22]  K. Yokote,et al.  Cell biology of diabetic nephropathy: Roles of endothelial cells, tubulointerstitial cells and podocytes , 2014, Journal of diabetes investigation.

[23]  J. Davidson,et al.  ANKRD1 Acts as a Transcriptional Repressor of MMP13 via the AP-1 Site , 2014, Molecular and Cellular Biology.

[24]  Panayiota Poirazi,et al.  A new microRNA target prediction tool identifies a novel interaction of a putative miRNA with CCND2 , 2012, RNA biology.

[25]  Mitsuo Kato,et al.  Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[26]  J. Fish,et al.  A primer on the role of microRNAs in endothelial biology and vascular disease. , 2012, Seminars in nephrology.

[27]  S. Hwang,et al.  Impact of miRNA deregulation on mRNA expression profiles in response to environmental toxicant, nonylphenol , 2011, Molecular & Cellular Toxicology.

[28]  Guohui Ding,et al.  Profile of MicroRNAs following Rat Sciatic Nerve Injury by Deep Sequencing: Implication for Mechanisms of Nerve Regeneration , 2011, PloS one.

[29]  M. Cunningham,et al.  MicroRNAs and their implications in toxicological research. , 2010, Toxicology letters.

[30]  C. Cheeseman.  Solute carrier family 2, member 9 and uric acid homeostasis , 2009, Current opinion in nephrology and hypertension.

[31]  D. Webb,et al.  Effects of endothelin receptor antagonism relate to the degree of renin-angiotensin system blockade in chronic proteinuric kidney disease. , 2009, Hypertension.

[32]  D. Webb,et al.  Urinary endothelin-1 in chronic kidney disease and as a marker of disease activity in lupus nephritis. , 2009, American journal of physiology. Renal physiology.

[33]  R. Quigg,et al.  MicroRNA‐377 is up‐regulated and can lead to increased fibronectin production in diabetic nephropathy , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  Stefanie Dimmeler,et al.  Role of microRNAs in vascular diseases, inflammation, and angiogenesis. , 2008, Cardiovascular research.

[35]  W. Berger,et al.  Mutation of solute carrier SLC16A12 associates with a syndrome combining juvenile cataract with microcornea and renal glucosuria. , 2008, American journal of human genetics.

[36]  R. Shivdasani.  MicroRNAs: regulators of gene expression and cell differentiation. , 2006, Blood.

[37]  D. Webb,et al.  The endothelin system and its antagonism in chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.

[38]  H. Shin,et al.  SLC12A3 (solute carrier family 12 member [sodium/chloride] 3) polymorphisms are associated with end-stage renal disease in diabetic nephropathy. , 2006, Diabetes.

[39]  J. Davidson,et al.  Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction. , 2015, The American journal of pathology.

[40]  J. Gross,et al.  Diabetic nephropathy: diagnosis, prevention, and treatment. , 2005, Diabetes care.